MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More!
No abstract is available for this record.
Bibliographic context
- Journal
- Psychiatric News
- Date
- 2026-03-29
- Source
- OpenAlex
- PubMed
- Unavailable
Topics and keywords
psilocybin DepressionChronic PainPharmacologyClinical Trial Clinical Trial PsilocybinMedicineAntipsychoticPsychiatryPimozideAntipsychotic AgentSchizophrenia (object-oriented programming)Intensive care medicineMEDLINEAtypical antipsychoticPlaceboPharmacologyPostpartum periodClinical trialHallucinogenPsychedelics and Drug StudiesPain Management and Placebo EffectDiverse academic research themes
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidenceAnnals of Medicine and Surgery · 2026-06-17Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trialPalliative Medicine · 2026-01-29Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 StudyPsychedelic Medicine · 2026-01-17Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 StudyPsychedelic Medicine · 2025-12-22Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatmentEClinicalMedicine · 2025-11-30Advancing treatment paradigms: the role of psilocybin in managing major depressive disorderAnnals of Medicine and Surgery · 2025-11-23